Title
Production and characterization of a highly pure RNA polymerase holoenzyme from Mycobacterium tuberculosis
Date Issued
2017
Access level
restricted access
Resource Type
journal article
Author(s)
Herrera-Asmat O.
Lubkowska L.
Kashlev M.
Kireeva M.L.
Publisher(s)
Academic Press Inc.
Abstract
Recent publications have shown that active RNA polymerase (RNAP) from Mycobacterium tuberculosis (MtbRNAP) can be produced by expressing all four subunits in a single recombinant Escherichia coli strain [1–3]. By reducing the number of plasmids and changing the codon usage of the Mtb genes in the co-expression system published by Banerjee et al. [1], we present a simplified, detailed and reproducible protocol for the purification of recombinant MtbRNAP containing the ω subunit. Moreover, we describe the formation of ternary elongation complexes (TECs) with a short fluorescence-labeled RNA primer and DNA oligonucleotides, suitable for transcription elongation studies. The purification of milligram quantities of the pure and highly active holoenzyme omits ammonium sulfate or polyethylene imine precipitation steps [4] and requires only 5 g of wet cells. Our results indicate that subunit assemblies other than α2ββ’ω·σA can be separated by ion-exchange chromatography on Mono Q column and that assemblies with the wrong RNAP subunit stoichiometry lack transcriptional activity. We show that MtbRNAP TECs can be stalled by NTP substrate deprivation and chased upon the addition of missing NTP(s) without the need of any accessory proteins. Finally, we demonstrate the ability of the purified MtbRNAP to initiate transcription from a promoter and establish that its open promoter complexes are stabilized by the M. tuberculosis protein CarD. © 2017
Start page
1
End page
10
Volume
134
Number
4
Language
English
Subjects
Scopus EID
2-s2.0-85016006342
PubMed ID
Source
Protein Expression and Purification
ISSN of the container
1046-5928
Sponsor(s)
This work was supported in part by a special grant contract and a travel award from CONCYTEC, Perú [FONDECYT N° 196-2013 and N° 033-2015-FONDECYT-DEC], by the National Institutes of Health [grant #R01GM032543], the U.S. Department of Energy Office of Basic Energy Sciences Nanomachine Program [contract #DE-AC02-05CH11231], and by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research (ZIA BC 010795).
Sources of information:
Directorio de Producción Científica